2021
Clinical Characteristics of Patients with Tick-Borne Encephalitis (TBE): A European Multicentre Study from 2010 to 2017
KOHLMAIER, B.; N. SCHWEINTZGER; M. SAGMEISTER; Vendula SVENDOVA; D. KOHLFURST et al.Základní údaje
Originální název
Clinical Characteristics of Patients with Tick-Borne Encephalitis (TBE): A European Multicentre Study from 2010 to 2017
Autoři
KOHLMAIER, B.; N. SCHWEINTZGER; M. SAGMEISTER; Vendula SVENDOVA; D. KOHLFURST; A. SONNLEITNER; M. LEITNER; A. BERGHOLD; E. SCHMIEDBERGER; F. FAZEKAS; A. PICHLER; J. REJC-MARKO; Daniel RUZEK; Lucie DUFKOVA; Darina CEJKOVA; Petr HUSA; Martina PÝCHOVÁ; Lenka KRBKOVÁ; Vaclav CHMELIK; Vera STRUNCOVA; D. ZAVADSKA; G. KARELIS; A. MICKIENE; J. ZAJKOWSKA; P. BOGOVIC; F. STRLE a W. ZENZ
Vydání
Microorganisms, Basel, MDPI, 2021, 2076-2607
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10606 Microbiology
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.926
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/21:00122108
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
tick-borne encephalitis; vaccine-preventable disease; meningomyelitis; central paresis; peripheral paresis
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 18. 8. 2021 09:04, Mgr. Tereza Miškechová
Anotace
V originále
Tick-borne encephalitis (TBE) virus is a major cause of central nervous system infections in endemic countries. Here, we present clinical and laboratory characteristics of a large international cohort of patients with confirmed TBE using a uniform clinical protocol. Patients were recruited in eight centers from six European countries between 2010 and 2017. A detailed description of clinical signs and symptoms was recorded. The obtained information enabled a reliable classification in 553 of 555 patients: 207 (37.3%) had meningitis, 273 (49.2%) meningoencephalitis, 15 (2.7%) meningomyelitis, and 58 (10.5%) meningoencephalomyelitis; 41 (7.4%) patients had a peripheral paresis of extremities, 13 (2.3%) a central paresis of extremities, and 25 (4.5%) had single or multiple cranial nerve palsies. Five (0.9%) patients died during acute illness. Outcome at discharge was recorded in 298 patients. Of 176 (59.1%) patients with incomplete recovery, 80 (27%) displayed persisting symptoms or signs without recovery expectation. This study provides further evidence that TBE is a severe disease with a large proportion of patients with incomplete recovery. We suggest monitoring TBE in endemic European countries using a uniform protocol to record the full clinical spectrum of the disease.